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The Drosophila oskar (osk) mRNA is unusual in having both coding and noncoding functions. As an mRNA,
osk encodes a protein which is deployed speciﬁcally at the posterior of the oocyte. This spatially-re-
stricted deployment relies on a program of mRNA localization and both repression and activation of
translation, all dependent on regulatory elements located primarily in the 3′ untranslated region (UTR) of
the mRNA. The 3′ UTR also mediates the noncoding function of osk, which is essential for progression
through oogenesis. Mutations which most strongly disrupt the noncoding function are positioned in a
short region (the C region) near the 3′ end of the mRNA, in close proximity to elements required for
activation of translation. We show that Bicoid Stability Factor (BSF) binds speciﬁcally to the C region of
the mRNA. Both knockdown of bsf and mutation of BSF binding sites in osk mRNA have the same con-
sequences: Osk expression is largely eliminated late in oogenesis, with both mRNA localization and
translation disrupted. Although the C region of the osk 3′ UTR is required for the noncoding function, BSF
binding does not appear to be essential for that function.
& 2015 Elsevier Inc. All rights reserved.1. Introduction
One way to categorize RNAs is by their coding potential, or lack
thereof. Members of one group, the mRNAs, have long open
reading frames and are translated, thereby performing a coding
function. The other group, consisting of RNAs without long open
reading frames, has many members with no consistent size or
organization. Such noncoding RNAs perform a wide variety of
structural, regulatory and enzymatic functions (Cech and Steitz,
2014). Often, these coding and noncoding roles are mutually ex-
clusive. Most of the exceptions involve small ORFs, which can
encode short peptides, in long noncoding RNAs (lncRNAs) (An-
drews and Rothnagel, 2014; Bazzini et al., 2014; Anderson et al.,
2015). Rarely, more dramatic overlap in function has been ob-
served for conventional mRNAs with long open reading frames.
The Xenopus VegT mRNA encodes a transcription factor required
for endoderm formation in the embryo. The same mRNA also has a
structural role in organization of the cytokeratin cytoskeleton
(Heasman et al., 2001; Kloc et al., 2005, 2007). Depletion of VegT
mRNA leads to fragmentation of the cytokeratin network in the
vegetal cortex of the oocyte. Sequences within much of the mRNAd).appear to act redundantly in controlling the organization of the
cytokeratin network, with a functional element contained within a
300 nt portion of the 3′ UTR sufﬁcient to induce depolymerization
of cytokeratin ﬁlaments (Kloc et al., 2011).
A second mRNA with essential coding and noncoding functions
is oskar (osk), from Drosophila. Osk protein is expressed speciﬁcally
at the posterior pole of the oocyte and early embryo, where it is
responsible for embryonic body patterning and germ cell forma-
tion (Lehmann and Nüsslein-Volhard, 1986; Kim-Ha et al., 1991;
Ephrussi et al., 1991). In the absence of Osk protein, oogenesis
progresses normally except for the failure to assemble posterior
pole plasm in the oocyte. Although eggs are produced, the em-
bryos fail to form abdominal segments and die. This coding role for
osk places substantial constraints on the mRNA sequence. The
open reading frame is constrained by the need to encode Osk
protein. In addition, noncoding regions are constrained by the
elaborate regulation required to restrict Osk protein expression to
a discrete subcellular domain: misexpression of Osk is just as le-
thal as loss of Osk (Ephrussi and Lehmann, 1992; Smith et al.,
1992). The osk mRNA is also needed, independent of its coding
role, for progression through oogenesis. In the absence of osk
mRNA a variety of defects emerge in the organization of the egg
chamber, with oogenesis arrested and no eggs produced (Jenny
et al., 2006; Kanke et al., 2015). These defects are present well
before the developmental stage when Osk protein ﬁrst appears,
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Instead, the osk mRNA 3′ UTR mediates the noncoding function,
placing constraints on the sequence of that region of the mRNA.
Deployment of Osk protein speciﬁcally at the posterior pole of
the oocyte involves a complex and coordinated program of mRNA
localization and translational control. osk mRNA is transcribed in
the nurse cells and transported into the oocyte through cyto-
plasmic bridges. Within the oocyte, osk mRNA is transiently en-
riched at different positions, culminating in persistent posterior
localization starting at stage 9; this is when Osk protein ﬁrst ac-
cumulates (Kim-Ha et al., 1991; Ephrussi et al., 1991; Kim-Ha et al.,
1995; Rongo et al., 1995; Markussen et al., 1995). Translational
repression serves to prevent expression from osk mRNA that has
not yet been localized, or has failed to become localized (Kim-Ha
et al., 1995; Nakamura et al., 2001, 2004; Wilhelm et al., 2003;
Besse et al., 2009). Once osk mRNA is localized, translational ac-
tivation must then override repression and allow Osk protein to be
made. Many factors and regulatory elements are required for this
regulation (Lipshitz and Smibert, 2000; Besse and Ephrussi, 2008;
Lasko, 2012), with most of the elements positioned in the 3′ UTR
(Kim-Ha et al., 1993, 1995; Munro et al., 2006; Reveal et al., 2010;
Vazquez-Pianzola et al., 2011; Jambor et al., 2014). Among the
elements are a number of binding sites for Bru (BREs and others),
clustered in two regions of the 3′ UTR: the AB region (close to the
coding region), and the C region (close to the 3′ end). Mutation of
all the BREs disrupts translational repression, revealing the role of
Bru as a repressor (Kim-Ha et al., 1995). By contrast, mutation of
only the C region cluster of BREs disrupts translational activation,
implicating Bru in activation, as well as repression (Reveal et al.,
2010). Similarly, mutation of the Bru type II binding sites (Reveal
et al., 2011) in the C region also disrupts translational activation
(Reveal et al., 2010).
The noncoding role of osk mRNA is mediated by the 3′ UTR
(Jenny et al., 2006). One part of this role is to sequester Bru, and
this relies on the Bru binding sites that also mediate regulation
(Kanke et al., 2015). Of greater importance to the noncoding re-
quirement for osk mRNA are sequences positioned close to the
mRNA 3′ end in the C region, including the Bru binding sites that
activate translation. These C region Bru binding sites contribute to
sequestration of Bru, but also play a separate and essential role in
osk noncoding function (Kanke et al., 2015). Additional sequences
essential for the noncoding function, which do not bind Bru, are
positioned nearby. Some of the sequences in this region appear to
act by binding poly(A) binding protein (PABP) (Vazquez-Pianzola
et al., 2011; Kanke et al., 2015). However, the mutations which
most strongly disrupt osk RNA function are not PABP binding sites,
and the factor expected to bind them has not been identiﬁed
(Kanke et al., 2015).
To better understand the roles of the C region of the osk mRNA
we searched for proteins which bind speciﬁcally to the essential
sequences. Here we show that Bicoid Stability Factor (BSF), a
protein previously found to act in stabilizing the bicoid mRNA
(Mancebo et al., 2001), binds to the osk C region, with binding
dependent on sequences most critical for osk RNA function early in
oogenesis. Surprisingly, we ﬁnd that the same sequences are also
required again, late in oogenesis, for regulation of osk expression.
BSF mediates this later function, as shown in two complementary
approaches. However, binding of BSF to the C region does not
appear to be responsible for the early function, as certain muta-
tions which substantially reduce BSF binding have no effect on the
noncoding role of osk mRNA. Why regulatory and functional ele-
ments should be superimposed in the RNA sequence is an intri-
guing question, as the osk 3′ UTR is quite large and thus does not
seem to be constrained in size.2. Results
2.1. Proteins that bind close to the 3′ end of the osk mRNA
To identify proteins that bind to the C region of the osk mRNA
3′ UTR, an afﬁnity puriﬁcation approach with a streptavidin-
binding aptamer (S1 aptamer) (Walker et al., 2008) was used.
Transcripts consisting of the ﬁnal 150 nt of the osk mRNA (the C
region) fused to the S1 aptamer (oskC::S1) were bound to strep-
tavidin beads and mixed with ovary extracts to allow assembly of
RNP complexes. After washing and recovery of the beads (the
pellet fraction), many proteins co-puriﬁed (Fig. 1A). These are ex-
pected to include a large number of non-speciﬁc binding proteins,
in addition to proteins bound speciﬁcally. Indeed, puriﬁcation
using just the S1 RNA yielded a very similar collection of proteins,
as judged by staining of total protein (Fig. 1A) and by detection of
individual proteins (Fig. 1B). As an initial test to identify proteins
bound speciﬁcally to the osk C region RNA, a parallel puriﬁcation
was performed with a mutant version of the RNA, carrying the
osk3'977-981mutation that (in the context of the intact oskmRNA)
largely abolishes osk RNA function (Kanke et al., 2015). One protein
not bound to oskC3'977-981::S1, or to S1 alone, migrated with an
apparent size of 150 kDa. Mass spectrometry of the 150 kDa band
identiﬁed Bicoid Stability Factor (BSF) as the most abundant pro-
tein. Western blot analysis of samples from the afﬁnity puriﬁca-
tions conﬁrmed this identiﬁcation (Fig. 1B). The western blots
were also probed for Bru, which binds to sites within the C region.
As expected, Bru did not bind the S1 RNA, but did bind both oskC::
S1 and oskC3'977-981::S1 (Fig. 1B; Kanke et al., 2015) (the 977-981
mutation does not affect the Bru binding sites; Fig. 1D).
Additional transcripts bearing other mutations were tested for
BSF binding to examine whether the correlation between loss of
BSF binding (Fig. 1C) and loss of osk RNA function (Fig. 1D) would
be extended. Mutant oskC3′984-988::S1 was as strongly defective
as oskC3′977-981::S1, with BSF binding reduced to a background
level. Mutants oskC3′970-974::S1 and oskC3′997-1001::S1 also had
substantially reduced BSF binding, although still above back-
ground. The remaining mutants, oskC3′990-994::S1 and oskC3′
1004-1008::S1, had strong BSF binding, similar to the wild type
level (Fig. 1C). Comparison of the effects of mutations on BSF
binding and noncoding osk RNA function reveals that two mu-
tants-oskC3'970-974 and oskC3′997-1001-were clearly impaired for
BSF binding (with the stronger effect for oskC3'970-974), yet both
retained a wild type level of osk RNA function (Fig. 1D; Kanke et al.,
2015). Thus, BSF binding appears not to be required for the non-
coding osk RNA function, although we cannot exclude the possi-
bility that the residual weak binding of these mutants is sufﬁcient
for this function.
2.2. bsf is required for accumulation of Osk protein
Although BSF binding to the osk C region does not appear to be
essential for the noncoding osk RNA function, such speciﬁc binding
is strongly suggestive of a functional role. Furthermore, the close
proximity of the BSF binding site to Bru binding sites required for
activation of osk mRNA translation raises the possibility that BSF
has a similar role. Characterization of Osk protein expression in a
bsf mutant is problematic, as oogenesis is blocked at an early stage
(De Renzis et al., 2007), while translation of osk mRNA occurs
much later in oogenesis. A knock down (KD) approach could avoid
this problem, as depletion of BSF might not occur quickly enough
to interfere with its role early in oogenesis. The TRiP-bsf transgene
(a strain from the Transgenic RNAi Project (TRiP), see Methods)
was expressed in the female germ line under control of GAL4
drivers. In initial experiments the nosGAL4::VP16-nos.UTR driver,
which is active at the earliest stages of oogenesis (Van Doren et al.,
Fig. 1. BSF binds close to the 3′ end of the osk mRNA. (A) Coomassie-stained gel of ovarian proteins from afﬁnity puriﬁcation. Input is the starting material. S and P are
supernatent and pellet fractions following puriﬁcation with the RNAs indicated at top (the osk RNA segment is the C region, the ﬁnal 150 nt of the 3′ UTR, either wild type or
with the indicated mutations). Amounts loaded, relative to the extract used for one puriﬁcation are: input and supernatent, 0.8%; pellet, 33.3%. The arrow indicates a
150 kDa protein which binds only to wild type oskC::S1 RNA. Because of the small amount of supernatent loaded, loss of binding does not lead to a high level of protein
detected in the supernatent fraction. (B) Western blot analysis of proteins in fractions from the afﬁnity puriﬁcations. (C) BSF and Bru binding, detected by western blot, to osk
3′ region mutant RNAs. The amounts loaded were as in panel A. Mutations 977–981 and 984–988 have the strongest effect on BSF binding, 970–974 and 997–1001 are
intermediate (with 977–1001 retaining the most binding activity), and 990–994 and 1004–1008 have no detectable effect. Names for these mutations reﬂect location of the
changes in the 3′ UTR, with position 1 being the ﬁrst nucleotide after the stop codon. (D) Diagram of the osk mRNA 3′ UTR with the sequence of osk C region showing
mutations and Bru binding sites. The 3′ UTR is shown as a gray rectangle with the AB and C regions indicated above (Kim-Ha et al., 1995). Individual Bru binding sites (BREs
and type II sites) are shown above the 3′ UTR as blue bars. Mutations that disrupt noncoding osk RNA function are shown below the 3′ UTR as yellow or red bars. The yellow
bars indicate a lesser effect of individual mutations (multiple Bru sites must be mutated to strongly disrupt the noncoding function). The red bars indicate mutations that
effectively eliminate that function. Simultaneous mutation of all C region Bru binding sites (as indicated by the red bars in parentheses) also eliminates the noncoding osk
RNA function. The C region is enlarged below to show the RNA sequence, the positions of Bru binding sites, mutations (below the sequence in lower case) and their effects on
osk RNA function and BSF binding.
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stages (Fig. S1), consistent with the prior analysis of the bsfmutant
(De Renzis et al., 2007). We therefore used the matalpha4-GAL-
VP16 Gal4 driver, which is not strongly active very early in oo-
genesis. To assess the efﬁciency of bsf KD, BSF protein wasmonitored in ovaries and early stage embryos (prior to the onset of
zygotic transcription) by western blot analysis. The level of BSF
was reduced in ovaries, with a much stronger reduction in early-
stage embryos (Fig. 2A).
Osk protein expression was monitored in the bsf KD ovaries by
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from an epitope-tagged osk transgene (Kim et al., 2015; Kanke and
Macdonald, 2015); both methods gave similar results. In the bsf KD
ovaries, Osk protein expression appeared normal up to stage 10
(Fig. 2B, Fig. S2), when deposition of the vitelline membrane in-
terferes with antibody accessibility. Further reducing BSF levels in
ﬂies also heterozygous for the bsfSH1181 mutation also had no effect
(Figs. 2B and S2). Consistent with this, the accumulation of osk
RNA was also similar to that in wild type egg chamber up to stage
10 (Fig. 2C).
To examine the later stages of oogenesis, when most of Osk
protein is made, an osk::GFP transgene with the entire osk gene
and regulatory elements was used (Fig. 2D) (Snee et al., 2007).
Detection of GFP ﬂuorescence circumvents the problem of the
vitelline membrane restricting access for antibodies. In a wild type
background Osk::GFP appeared at the posterior pole of stage
9 oocytes, just as for endogenous Osk. This distribution persisted
for the remainder of oogenesis, with the signal strength increasing
at the later stages. For the bsf KD egg chambers, the early pattern
of Osk::GFP was similar to that in wild type. However, at later
stages of oogenesis defects in Osk::GFP expression appeared: al-
though most late stage oocytes retained the high level typically
found in wild type, some had either weak or undetectable levels
(Fig. 2E). To further enhance depletion of BSF, the same experi-
ments were also performed with ﬂies heterozygous for bsfSH1181;
the defects were stronger, with most oocytes having no detectable
Osk::GFP (Fig. 2E).
We also monitored localization of osk::GFP mRNA in the bsf KD.
Because the effect on Osk::GFP protein was variable, double-la-
beling experiments were performed to detect both the mRNA and
protein in the same samples and thus reveal any correlation in
defects. For this analysis early embryos were used, as the vitelline
membrane of late stage egg chambers interferes with the in situ
hybridization method. In wild type embryos both Osk::GFP protein
and osk::GFP RNA were present at high levels at the posterior pole.
By contrast, most embryos from bsf KD mothers heterozygous for
bsfSH1181 had weak or undetectable levels of both Osk::GFP protein
and osk::GFP mRNA, with a consistent correlation between re-
duced mRNA and reduced protein (Fig. 2F).
The knockdown results implicate BSF in posterior accumulation
of Osk protein and osk RNA. BSF could have an indirect effect, al-
though the binding of BSF to the osk mRNA suggests a direct role.
Furthermore, BSF is present at the posterior pole of the oocyte
where osk mRNA is localized (Fig. 2G), consistent with persistent
binding and a direct role. This posterior crescent of BSF was sub-
stantially reduced in the bsf KD (Fig. 2G).Fig. 2. bsf is required for a late phase of Osk protein expression. (A) Efﬁciency of bsf KD in
control. Samples were wt (w1118), KD (TRiP-bsf transgene withmatalpha4-GAL-VP16), and
BSF (top) or anti-α-Tubulin (bottom). (B) Osk expression is normal in the bsf KD up to sta
magniﬁcation images of just Osk::HA from other examples of egg chambers are shown at
bsfSH1181. DNA, red; Osk::HA, green. Scale bars in this and other panels are 20 mm. Genoty
matalpha4-GAL-VP16 oskA87/TM3Sb. bsf KD is þ /þ ; oskHA matalpha4-GAL-VP16 oskA87/TRiP
osk mRNA is localized normally in bsf KD up to stage 10 of oogenesis. Left and middle p
magniﬁcation) and the right panels show oskmRNA. For the Stau panels DNA is red and S
cells is background). (D) Schematic diagram of the osk::GFP transgene for examination of
of the osk coding region. All osk sequences, including the 3′ UTR and transcriptional con
Panels show the posterior portion of stage 13–14 egg chambers, with examples of the dif
signal, while lower panels also show DNA (and background TOPRO-3 staining). The tabl
genotypes as in panel B. DNA, red; Osk::GFP, green. (F) Osk::GFP protein (upper) and osk:
single copies in bsfþ /þ or bsf KD in bsfþ / background. Osk::GFP protein and osk::GFP RN
is from the same embryo). This correlation between levels of localized protein and mRNA
values applying to both protein and mRNA. Genotypes for the samples in E and mothers o
bsf KD: osk::GFP/þ; matalpha4-GAL-VP16 oskA87/TRiP-bsf. bsf KD in bsfþ / background: os
wild type and in bsf KD. For each genotype the posterior of an egg chamber is shown a
Although the anti-BSF antibody shows poor penetration into the egg chamber, a crescent
along the entire cortex). Note that the follicle cell BSF is not affected by the bsf KD, wh
(TOPRO-3), red; BSF, green.2.3. Loss of BSF binding affects Osk protein expression but not osk
mRNA stability
To complement the studies in which BSF protein is depleted,
we also examined the consequences of mutating the osk mRNA to
disrupt BSF binding. Similar results from both approaches would
strengthen the argument that BSF regulates Osk expression. Fur-
thermore, defects in osk expression associated with loss of BSF
binding would strongly support the model that BSF acts directly.
Four mutations in the osk 3′ UTR C region affected BSF binding:
the 3′970–974 and 3′997–1001mutations reduced binding, and the
3′977–981 and 3′984–988 mutations further reduced binding to
background levels (Fig. 1C). For analysis of Osk expression, the
standard approach is to place a mutant transgene in an osk RNA
null background so that it is the only source of osk mRNA and
protein. Two features of osk mRNA create complications for ana-
lysis of these transgenes.
One complication involves the bifunctionality of osk mRNA,
with its coding and noncoding roles. The noncoding function of
osk mRNA is required for progression through oogenesis: in the
absence of osk mRNA, oogenesis is arrested at stage 6/7, before the
normal onset of Osk protein expression (Jenny et al., 2006). When
tested in the osk RNA null background, most osk transgenes pro-
vide full osk RNA function, enabling progression through oogenesis
and evaluation of Osk expression. However, the two mutations
that most strongly disrupt BSF binding, 3′977–981 and 3′984–988,
essentially eliminate osk RNA function (Kanke et al., 2015). Con-
sequently, oogenesis remains arrested when osk transgenes with
these mutations are tested in osk RNA null ﬂies, and an effect on
Osk protein expression cannot be evaluated. The solution is to co-
express these mutants with a helper RNA, an osk mRNA that
provides the noncoding function, but cannot itself make Osk
protein. Thus, oogenesis progresses normally, and the ability of a
mutant transgene to make Osk protein (or embryonic patterning
activity) can be monitored. A helper osk mRNA that has full RNA
function but is protein null and cannot make Osk protein is osk54,
which has a small insertion in the ﬁrst exon coding region that
alters the reading frame and introduces a stop codon (Kim-Ha
et al., 1991).
The second complication is that some forms of osk translational
control are subject to the phenomenon of regulation in trans
(Reveal et al., 2010). The concept of regulation in trans has been
invoked to explain how translational control elements on one RNA
molecule can inﬂuence the translational regulation of another RNA
molecule. We hypothesized that regulation in trans is made pos-
sible by assembly of the RNAs in particles, placing them in closeovaries and early embryos, as detected by western blot analysis. w1118 was used as a
control (TRiP-bsf transgene without GAL4 driver). Proteins were detected using anti-
ge 10 of oogenesis. Panels show detection of nuclei and Osk::HA (Methods). Higher
right. bsf KD was as in panel A. For bsf KD in bsfþ / , the ﬂies were heterozygous for
pes used were as follows (only relevant genes are indicated). bsfþ /þ is þ /þ; osk::HA
-bsf. bsf KD in bsfþ / is bsfSH1181/þ; osk::HA matalpha4-GAL-VP16 oskA87/TRiP-bsf. (C)
anels show Stau protein (which colocalizes with osk mRNA; middle panel at higher
tau is green. For the in situ hybridization panels osk RNA is red (the signal in follicle
late-stages of oogenesis, which is a genomic osk gene with GFP appended to the end
trol elements, remain present. E. Osk::GFP expression in late-stage egg chambers.
ferent levels of posterior Osk::GFP accumulation. Upper panels are just the Osk::GFP
e below the images shows the percentage of oocytes in each category for the same
:GFPmRNA (lower) double-labeling in early-stage embryos. osk::GFP expressed from
A (upper and lower panels, respectively) in early-stage embryos (each pair of panels
was observed in all embryos. The table below the images is as in panel E, with the
f samples in F were as follows. bsfþ /þ: osk::GFP/þ; matalpha4-GAL-VP16 oskA87/TM2.
k::GFP/bsfSH1181; matalpha4-GAL-VP16 oskA87/TRiP-bsf. (G) Immunodetection of BSF in
t left, with the boxed posterior region shown at higher magniﬁcation at the right.
of BSF is detected speciﬁcally at the posterior pole of the oocyte (lower levels appear
ich is limited to the germline cells by use of the matalpha4-GAL-VP16 driver. DNA
Fig. 3. Effects of mutating Bru and BSF binding sites on osk activity and protein binding. (A) Patterning activity of osk transgenes with 3′ UTR C region mutations, tested as
single copies in the oskA87/Df(3R)osk background (osk RNA) (top), with osk54 (middle) or osk IBE (bottom; this transgene has all IBEs mutated) also present. For each
genotype, the fraction of cuticles with the number of abdominal segments indicated by colors is given as a percentage. The number of abdominal segments corresponds to
the level of osk activity, with wild type embryos having eight. Mutants which produce no or few embryos lack the noncoding osk RNA function required for progression
through oogenesis. ND is not determined (because of the very modest patterning defects of the osk3′997–1001 mutant). Transgene mRNA levels differ somewhat (Kanke
et al., 2015), but the strong levels of osk patterning activity they produce when co-expressed with the osk54 mRNA (and thus subject to regulation in trans) provides a point of
reference for interpreting their activities in the absence of regulation in trans. (B) Patterning activity of osk transgenes, tested as single copies in the oskA87/Df(3 R)osk
background (osk RNA). (C) Levels of oskmRNAs for the transgenes in panel B, relative to the amount from a wild type osk transgene. Data are reproduced from (Kanke et al.,
2015). (D) BSF and Bru binding, detected by western blot, to oskC::S1 RNAs (the ﬁnal 150 nt of the osk 3′ UTR) with mutated type II Bru binding sites. The amounts loaded
were as in Fig. 1A. As in Fig. 1, the 970–974 mutation reduced BSF binding but not to the background level seen with the S1 RNA. Mutation of the Bru type II sites did not
dramatically reduce Bru binding, as the high afﬁnity BREs are also present in all of the oskC::S1 RNAs.
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underlie certain forms of regulation (e.g. between molecules
bound to distant parts of an mRNA, such as the 5′ cap and the 3′
UTR) would now have the potential to occur between different
RNA molecules. As an example, the phenomenon of regulation in
trans is displayed by osk transcripts with mutations in the C region
Bru binding sites. When expressed as the only osk mRNA in an osk
RNA null background, osk C BRE is strongly defective in activation
of translation (Fig. 3A). However, this defect is largely eliminatedby co-expression with other osk transcripts which have wild type C
region BREs, but are themselves unable to make functional Osk
protein (e.g. osk54) (Fig. 3A) (Reveal et al., 2010). The only source of
functional Osk protein in this experiment was from osk C BRE ,
and so its activation defect must have been suppressed.
Just as the osk C BRE regulatory defect can be rescued in trans,
a regulatory defect of osk3′977–981 and osk3′984–988 mutants
might also be rescued in trans. The problem is that we cannot test
the osk3′977–981 and osk3′984–988 mutants in the absence of
Fig. 4. Loss of BSF binding affects Osk protein expression but not oskmRNA stability. (A) Schematic diagram of oskmRNAs used in the assays. The oskT140::GFP transgene has
wild type or mutant versions of the 3′ UTR. All oskT140::GFP transgenes were inserted at the same genomic site by phiC31 transgenesis to avoid position effects that might
alter transcription levels. The osk IBE- transgene has the A subset of IBE mutations (Munro et al., 2006) in the 3′ UTR. (B) OskT140::GFP in stage 10 oocytes. All oskT140::GFP
transgenes were co-expressed with osk IBE- (to provide the noncoding osk RNA function for the mutants) in the osk0/Df(3R)osk background. Panels show the posterior portion
of stage 10 egg chambers; Left panel is from oskþ; Middle panel is from oskT140::GFP-977–981; Right panel is from oskT140::GFP-984–988. DNA in red and OskT140::GFP in
green. The scale bar is 20 mm. (C) OskT140::GFP in stage 13–14 egg chambers. The panels are examples of the different level of OskT140::GFP accumulation at the posterior of
the oocyte: strong, weak, or very weak/undetectable. The upper panels are OskT140::GFP only, and the lower panels show both OskT140::GFP and DNA. The table below the
images shows the percentage of oocytes in each category for the oskT140::GFP transgenes with wild type or mutant osk 3′ UTRs. DNA in red and OskT140::GFP in green. The
scale bars for B, C and D are 20 mm. (D) OskT140::GFP protein and osk::GFP RNA (upper and lower panels, respectively) in early-stage embryos (each pair of panels is from the
same embryo). This correlation between levels of localized protein and mRNA was observed in all embryos. The table below the images is as in panel B, with the values
applying to both protein and mRNA. (E) Levels of mRNA measured by qPCR. RNA levels were measured with mGFP6 oligos (two different oligo pairs) to detect only oskT140::
GFP transgene mRNAs. Error bars indicate standard deviation, n is 9 for each sample. The oskT140::GFP transgenes make use of mGFP6 (Methods). Genotypes for B–E
(maternal genotypes for embryos) were as follows. oskþ: oskT140::GFP/osk IBE; osk0/Df(3R)osk. 977–981: oskT140::GFP 3′977–981/osk IBE; osk0/Df(3R)osk. 984–988:
oskT140::GFP 3′984–988/osk IBE; osk0/Df(3R)osk.
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because a helper osk mRNA is required to provide the noncoding
osk RNA function these mutants lack, and thus allow develop-
mental progression to the later stages of oogenesis when Osk
protein is expressed.
A solution to this experimental challenge is to use osk IBE
transgenes to provide the helper RNA. These transgenes have
mutations in binding sites for Imp, which are spread throughout
the osk 3′ UTR. Mutation of certain subsets of IBEs or all IBEs have
the same effects: a complete absence of Osk protein, with the
noncoding osk RNA function remaining intact (Munro et al., 2006).
Importantly, the osk IBE mutant does not participate in regula-
tion in trans: its activation defect is not rescued at all by the
presence of osk mRNAs with intact IBEs (Reveal et al., 2010), and it
does not strongly rescue the activation defects of other osk mu-
tants (e.g. osk C BRE , Fig. 3A; unpublished). Therefore, the osk
IBE mRNA can be used to provide the early noncoding osk RNA
function that mutants osk3′977–981 and osk3′984–988 lack, but
the osk IBE mRNA will not inﬂuence the ability of these mutants
to make Osk protein later in oogenesis.
Transgenes with mutations that disrupt BSF binding, or with
the interdigitated mutation that does not affect BSF binding, were
tested for their ability to provide osk patterning activity in the
presence of either osk54 or osk IBEhelper RNAs (Fig. 3A). The
mutant with normal BSF binding, osk3′990–994, is largely defec-
tive in the noncoding osk RNA function, and produces very few
eggs (Kanke et al., 2015) (Fig. 3A). The osk54 helper RNA fully
rescued the noncoding function of osk3′990–994, allowing pro-
duction of embryos, and these embryos had no patterning defects.
Similar results were obtained with osk3′990–994 in combination
with the osk IBE helper RNA. From these results we conclude that
the osk3′990–994 mutation affected only the noncoding osk RNA
function, and did not substantially alter regulation of osk
expression.
By contrast, the mutants with BSF binding defects all displayed
evidence of reduced osk patterning activity (Fig. 3A). The osk3′
977–981 and osk3′984–988 mutants have the strongest defects in
BSF binding. Because these mutants are completely defective in
the noncoding osk RNA function (Kanke et al., 2015), they produce
no embryos in the absence of a helper osk mRNA. When these
mutants were co-expressed with the osk54 helper RNA, patterning
was effectively wild type. However, when co-expressed with the
osk IBE helper RNA, only very low levels of osk patterning activity
were produced. From these results we conclude that the osk3′977–
981 and osk3′984–988 mutants each had defects in osk expression,
as observed when co-expressed with the osk IBE helper RNA.
Furthermore, these defects could be rescued in trans, as shown by
the absence of signiﬁcant patterning defects when the osk3′977–
981 and osk3′984–988 mutants were co-expressed with the osk54
helper RNA. Thus, the mutants with the strongest defects in BSF
binding had reduced or almost undetectable osk activity.
The osk3′970–974 and osk3′997–1001 mutants also interfere
with BSF binding but to a lesser degree. These mutants can pro-
duce embryos without a helper RNA, because neither affects the
noncoding osk RNA function (Kanke et al., 2015). The embryos
from both mutants were missing abdominal segments, the phe-
notype caused by reduced levels of osk activity. The severity of the
patterning defects of the osk3′970–974 and osk3′997–1001 mu-
tants correlated with the effect on BSF binding, although the
weaker osk3′997–1001 mutant also has a lower level of mRNA
(Kanke et al., 2015). Using the helper RNAs to test for regulation in
trans, the patterning defects of osk3′970–974 and osk3′997–1001
were fully rescued by co-expression with osk54, and only very
weakly rescued by co-expression with osk IBE . Thus, all of the
mutants with defects in BSF binding had patterning defects con-
sistent with reduced osk activity, and all displayed regulation intrans.
To conﬁrm that the loss of osk patterning activity of the mu-
tants unable to bind BSF was due to a defect in Osk protein ex-
pression, we monitored Osk::GFP produced by oskT140::GFP
transgenes, either a wild type version or versions bearing the 3′
977–981 or 3′984–988 mutations (which most strongly affect BSF
binding) (Fig. 4A). The transgenes were co-expressed with the osk
IBE helper to provide noncoding osk RNA function. The results
were similar to those obtained with the bsf KD. No change in Osk::
GFP expression between the wild type and mutants was detected
up to stage 10 of oogenesis (Fig. 4B). However, in late stage oocytes
and early stage embryos the mutants had dramatically reduced
levels of Osk::GFP (Fig. 4C and D).
One explanation for the defects caused by the 3′977–981 and 3′
984–988 mutations is destabilization of the mRNA, an option
suggested by the role of bsf in stabilizing bcd mRNA (Mancebo
et al., 2001). To ensure that transgene mRNA levels were not in-
ﬂuenced by differences in transcription, all of the oskT140::GFP
transgenes used in Fig. 4 were introduced by phiC31 transgenesis
to the same target site in the genome, thus avoiding variation in
transcription due to insertion site. Neither of the mutants had
decreased mRNA levels relative to the control (Fig. 4E), demon-
strating that mutation of the BSF binding sites does not cause
destabilization of the mRNA.
2.4. Close proximity in Bru and BSF binding
The 3′970–974 mutation disrupts a type II Bru binding site
(Reveal et al., 2010, 2011), interferes with BSF binding (Fig. 1D),
and causes reduced osk patterning activity (Fig. 3A). A mutant with
both of the osk C region type II Bru binding sites disrupted (osk C
II) has a strong defect in activation of osk mRNA translation
(Reveal et al., 2010) (Fig. 3B), and the patterning defect of the osk C
II mutant had been suggested to result from the loss of Bru
binding to the type II sites (Reveal et al., 2010). Now, knowing that
mutation of the 3′ type II site also affects BSF binding, we re-
evaluated this conclusion.
Patterning activities were compared for transgenes with the
different combinations of mutant type II Bru binding sites: both
sites mutated (osk3′920–923,970–974, which is osk C II), only the
5′ site mutated (osk3′920–923, or osk C 5′II), or only the 3′ site
mutated (osk3′970–974, or osk C 3′II)(Fig. 3B). The original C II
mutant with both sites mutated has the weakest patterning ac-
tivity, even though this mRNA is present at a higher level than the
others (Fig. 3C). Comparing the transgenes with single type II sites
mutated revealed that they make unequal contributions to osk
activity: mutation of just the 5′ site had no effect on patterning,
while mutation of just the 3′ site led to partial osk activity (as
already described above). This suggests some degree of re-
dundancy between the two sites, but with the 3′ site having a
more important contribution. Redundancy could reﬂect the fact
that both sites bind Bru (Reveal et al., 2010, 2011), with Bru bound
to either site providing at least partial function. A similar argu-
ment cannot be made for BSF, as mutation of the 5′ site alone had
no effect on BSF binding, nor did mutation of the 5′ site enhance
the reduction of BSF binding caused by mutation of the 3′ site
(Fig. 3D; note that the effects on Bru binding in this assay are
subtle, as the high afﬁnity BREs are also present in the C region
RNA substrate). The more substantial contribution of the 3′ site to
osk activity could be due to its role in binding both Bru and BSF. An
understanding of how this sequence both constitutes a Bru bind-
ing site and is required for strong BSF binding will require an in-
depth analysis of BSF binding properties. Nevertheless, there is no
need to invoke competition for Bru and BSF binding to the same
sequence. Instead, Bru bound to the type II site could enhance or
facilitate interaction of BSF with adjacent sequences, which are
Fig. 5. BSF binding is not required to maintain poly(A) tail length. (A) Schematic diagram of the circularized RT-PCR (cRT-PCR) assay, to selectively measure poly(A) tail
length for oskT140::GFPmRNAs when co-expressed with osk IBE- mRNA. The osk IBE transgene has the A subset of IBE mutations (Munro et al., 2006) in the 3′ UTR. The use
of a primer (oligo 2) which anneals to GFP ensures that only the oskT140::GFP mRNAs are substrates for both cDNA synthesis and PCR in the assay. (B)–(E) Lengths of poly
(A) tails for individual cloned PCR products from late-stage egg chambers (B)–(C) and early-stage embryos (D)–(E). For panels B and D the sequence traces are for a single
clone, with the range in poly(A) tail length given above. P values are indicated by ***po0.001; ns, not signiﬁcant with p40.05. Genotypes are the same as in Fig. 4.
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and BSF by coimmunoprecipitation (data not shown). However,
the fraction of each protein engaged in such an interaction-whe-
ther direct, or dependent on both binding to the same RNA-might
be small, as only a tiny fraction of each protein is colocalized with
osk mRNA at the posterior pole of the oocyte, and thus difﬁcult to
detect by this approach.
2.5. BSF and osk mRNA polyadenylation
The position of the BSF binding site in the osk mRNA, close to
the poly(A) tail, raises the possibility that BSF activates translation
by promoting cytoplasmic polyadenylation. This possibility is also
suggested by the role of BSF in processing and adding poly(A) tails
to polycistronic mitochondrial RNAs, although this reaction is
substantially different from cytoplasmic polyadenylation of con-
ventional eukaryotic mRNAs (Bratic et al., 2011). To measure poly
(A) tail lengths for the mRNAs with mutations in the BSF binding
site, the assay must be able to distinguish between those mRNAs
and the osk IBE helper mRNA (which must be present to provide
osk noncoding RNA function). One useful approach relies on cir-
cularization of the mRNA, followed by mRNA-speciﬁc reverse
transcription and PCR (using a primer complementary to GFP se-
quences present only in the mRNAs with the mutated BSF binding
site), and sequencing (Fig. 5A, Section 4). The results showed a
range of poly(A) tail length from 20 to almost 100 in all genotypes,
consistent with a previous direct measurement of wild type osk
mRNA (Lie and Macdonald, 1999). Neither oskT140::GFP 3′977–981
nor oskT140::GFP 3′984–988 had consistently shorter poly(A) tailsthan the oskT140::GFP mRNA control (Fig. 5B and C). This suggests
that BSF function in osk expression is not by controlling
polyadenylation.3. Discussion
Here we focus on two features of the work. One is the identi-
ﬁcation of BSF as a factor required for the complex post-tran-
scriptional regulation of osk mRNA. The second is the discovery
that RNA elements with seemingly unrelated responsibilities, and
acting at different times during oogenesis, are superimposed in the
osk mRNA.
BSF is a one of a family of proteins harboring the penta-
tricopeptide (PPR) motif, which acts as an RNA binding domain
(Barkan et al., 2012; Filipovska and Rackham, 2013; Yin et al.,
2013). The vast majority of PPR proteins are from plants and have
multiple copies of the motif, typically with no other recognizable
domain (Lurin et al., 2004). When BSF was ﬁrst characterized,
methods for detection of protein motifs reported seven copies of
the PPR in BSF: four tandem copies near the amino terminus, and
three separated copies in the carboxyl-terminal half (Mancebo
et al., 2001). By the current deﬁnition of the PPR domain, pre-
sumably reﬁned with the large number of additional examples
identiﬁed since 2001, BSF has only a single PPR domain. However,
the entire amino-terminal region containing the four tandem re-
peats is highly conserved with the closest human homolog of BSF,
Leucine-rich PPR motif-containing protein (LRPPRC), in which all
four PPRs continue to be identiﬁed (Mili et al., 2001; Sterky et al.,
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like domains of BSF, it is possible that not all have RNA binding
activity.
PPR-containing proteins have been implicated in a wide range
of processes, ranging from transcription, to mRNA export from the
nucleus (Mili et al., 2001; Topisirovic et al., 2009; Tsuchiya et al.,
2004), to various forms of post-transcriptional regulation in both
cytoplasm and organelles (Sasarman et al., 2010; Gohil et al.,
2010). Thus, the presence of this motif suggests a function in nu-
cleic acid transactions, but is not indicative of a speciﬁc role. Ex-
cept for the PPR proteins in which other domains dictate function
(Zehrmann et al., 2011), proteins of this type may serve primarily
in binding to nucleic acids, with the outcome of that binding
probably speciﬁed by associated factors.
BSF was initially identiﬁed as a cytoplasmic ovarian protein
which bound to bicoid mRNA, playing a redundant role in stabili-
zation of the mRNA (Mancebo et al., 2001). BSF also binds DNA,
and was puriﬁed on the basis of speciﬁc binding to a short DNA
sequence found in the promoter region of genes transcribed very
early in embryogenesis (De Renzis et al., 2007). Whether BSF binds
to and activates transcription of associated genes in vivo remains
uncertain: another protein, Zelda, binds the same sequence and is
required for early transcription (Liang et al., 2008). In ﬂight muscle
BSF appears in sarcomeric bands. BSF, like LRPPRC, is also found in
mitochondria and this may be the predominant location at least in
some tissues (Bratic et al., 2011). Within mitochondria, reducing
the level of BSF affects mitochondrial transcription, mRNA poly-
adenylation, and translation (Bratic et al., 2011).
We have now identiﬁed a further role for BSF, in regulation of
osk mRNA. Complementary approaches, either disrupting BSF
binding to the mRNA or reducing the level of BSF, had similar ef-
fects: reduction or loss of both posteriorly-localized oskmRNA and
Osk protein late in oogenesis and in embryos. The defects were
strongest with osk transgenes bearing mutations that reduced BSF
binding to background levels, and less severe with KD of bsf. This is
not surprising, as the KD does not eliminate BSF. Regulation of osk
mRNA occurs at several levels, and several options can explain the
observed defects. We have ruled out one option, an effect on osk
mRNA stability. Two other options are most likely for the loss of
Osk protein accumulation: disruption of mRNA localization or
translational activation. Neither mutation of the BSF binding site
nor KD of bsf affects the initial phase of osk mRNA localization to
the posterior pole of the oocyte. However, the mechanism of lo-
calization can change as oogenesis progresses and BSF could act in
a later phase, having a role in capture of mRNA circulated in the
oocyte by cytoplasmic ﬂow (Glotzer et al., 1997). Because only
localized osk mRNA is efﬁciently translated, a defect in mRNA lo-
calization would result in loss of Osk protein expression. Alter-
natively, BSF could act in a late phase of translational activation,
when the bulk of Osk protein accumulates (Snee et al., 2007).
Because Osk protein is required for anchoring of osk mRNA, a
defect in production of Osk protein would result in dispersal of the
mRNA. Distinguishing between possible roles in mRNA localization
or translational activation is simple if one defect clearly precedes
the other, but no difference in the timing of the defects has been
detected.
If BSF more directly affects translation, a possible mechanism
involves the poly(A) tail. Typically, longer tails are correlated with
enhanced translation, and the length of the tail can be extended in
the cytoplasm (Jacobson et al., 1996; Wickens et al., 1996; Preiss
and Hentze, 1998). As ﬁrst shown in Xenopus, CPEB protein bound
to a regulatory element (CPE) positioned close to the poly(A) tail
directs cytoplasmic polyadenylation and translational activation
(Hake and Richter, 1994). We found no decrease in poly(A) tail
length for osk mRNAs with mutations in the BSF binding sites, but
instead a small increase. Thus it appears that BSF does not activateosk mRNA translation by extension of the poly(A) tail. A caveat to
that conclusion is that an effect on a very small subpopulation of
osk transcripts would not have been detected.
3.1. Superimposition of RNA elements for function and regulation
osk mRNA has both coding and noncoding functions. In the
absence of osk mRNA there are multiple defects beyond those
caused later in oogenesis by the absence of Osk protein: the kar-
yosome fails to condense, multiple proteins are displaced from
large RNPs (nuage and sponge bodies), the same proteins become
enriched in the somatic follicle cells, and oogenesis is arrested
(Jenny et al., 2006; Kanke et al., 2015). How the presence of osk
RNA prevents these problems is only partially understood. It is
noteworthy that sequences critical for osk RNA function overlap
with sequences which mediate regulation by Bru and BSF. This
raises the question of whether the same RNA elements serve both
roles, which might imply some mechanistic commonalities in RNA
function and regulation, or if different types of RNA elements are
superimposed on one another.
One biochemical role of osk mRNA in its noncoding function is
to sequester Bru, presumably preventing Bru from binding in-
appropriately to low afﬁnity sites in normally unbound mRNAs,
and thereby altering their regulation (Kanke et al., 2015). Muta-
tions which reduce Bru binding also cause the other defects as-
sociated with absence of osk mRNA (karyosome formation, protein
distributions, arrest of oogenesis), but to a lesser degree. Thus,
sequestration of Bru is one component of osk RNA function, but
not the main component.
The C region Bru binding sites have an additional role in the
noncoding osk RNA function, with mutation of all C region sites
being effectively equivalent to complete absence of osk mRNA. By
contrast, mutation of all AB region Bru binding sites only reduces
the noncoding osk RNA function, and so there must be a unique
property of the C region sites. It is not higher afﬁnity for Bru, as AB
region sites bind Bru more strongly (Kim-Ha et al., 1995; Kanke
et al., 2015). Rather, the special feature of the C region sites is most
likely their close proximity to other sequences essential for non-
coding osk RNA function. Curiously, the C region Bru binding sites
can also be distinguished from those in the AB region by their role
in translational activation: mutation of C region sites disrupts ac-
tivation, while mutation of AB regions sites does not.
Other sequences in the osk 3′ region also have roles in both
regulation and noncoding osk RNA function. A-rich sequences
(ARSs) close to the poly(A) tail bind PABP (Vazquez-Pianzola et al.,
2011). Mutations affecting some or all of the ARSs cause partial
defects in both the noncoding function and osk mRNA regulation
(Vazquez-Pianzola et al., 2011; Kanke et al., 2015) (unpublished).
How the ARSs contribute to either RNA function or regulation is
not entirely understood. In pabp mutants osk mRNA is destabi-
lized, but it is uncertain if this reﬂects loss of PABP binding to the
poly(A) tail or to the ARSs (Vazquez-Pianzola et al., 2011). How-
ever, mutation of an ARS does affect osk regulation without al-
tering mRNA stability (Kanke et al., 2015). Thus, it is unknown if
the mechanisms used by PABP and the ARSs for osk regulation and
noncoding osk function are shared or distinct.
Mutations which disrupt BSF binding have defects in osk reg-
ulation, and the evidence presented here strongly supports the
conclusion that BSF mediates this regulation. Two of these muta-
tions, osk3′977–981 and osk3′984–988, also have severe effects on
noncoding osk RNA function, almost identical to absence of osk
mRNA. However, other mutations which disrupt BSF binding (osk3′
970–974 and osk3′997–1001), albeit to a lesser degree, have no
detectable effect on noncoding osk RNA function (Kanke et al.,
2015). Thus, the ability to bind BSF does not correlate with the
ability to provide noncoding osk RNA function. Instead, the
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in the critical osk 3′ UTR C region. One function, mediated by BSF
binding, acts in regulation of osk mRNA expression late in oo-
genesis. A second function, which presumably involves interaction
with another factor, is essential for the action of osk as a noncoding
RNA early in oogenesis.
The high density of RNA elements for function or regulation in
the C region of the osk 3′ UTR is paralleled by an extremely high
degree of phylogenetic conservation. The segment containing the
cluster of Bru, BSF and PABP binding sites has the highest level of
sequence conservation across the entire 3′ UTR, and is more con-
served than much of the osk coding region (UCSC genome browser
phastCons analysis). An intriguing question is why the functional
and regulatory elements are so densely packed and superimposed.
Reuse of the same sequences for multiple purposes is a well
known feature of certain viruses, imposed by size constraints
(Sanger et al., 1977). A similar explanation seems unlikely for osk,
as the 3′ UTR is quite large (over 1000 nucleotides) and there is no
obvious reason why a small further enlargement would pose a
problem. It will be interesting to determine if these elements are
subject to a positional constraint, relying on mechanisms which
require close proximity to the 3′ end of the mRNA and thus forcing
them to be superimposed.4. Materials and methods
4.1. Flies and transgenes
For bsf KD, TRiP line y sc v; P{TRiP.HMS01022}attP2 (Bloo-
mington stock 34550) was used. Mutants were bsfSH1181 (De Renzis
et al., 2007), osk54 (Lehmann and Nüsslein-Volhard, 1986), oskA87
(Jenny et al., 2006), osk0 (Kanke et al., 2015), and Df(3R)osk (Reveal
et al., 2010). The osk IBE transgene used in Figs. 4 and 5 has the A
set of IBEs mutated, and the version used in Fig. 3 has all IBEs
mutated. Both behave identically, with a complete absence of Osk
protein produced (Munro et al., 2006), and the same very low level
of ability to rescue in trans the activation defect of osk C BRE
(unpublished). The different versions of osk IBE were used to
facilitate ﬂy stock construction. The osk::HA transgene reproduces
endogenous osk expression and function (Kim et al., 2015; Kanke
and Macdonald, 2015). The osk::GFP transgene used in Fig. 2 (Snee
et al., 2007), had been remobilized in the lab of Liz Gavis to restore
expression. The osk transgenes with 3′ UTR C region mutations
were those described (Kanke et al., 2015), or had the same mu-
tations but with mGFP6 (Haseloff, 1999) inserted after T140 (M139
is the aminoterminal end of Short Osk). The latter set were con-
structed in vector pGE-attB (Huang et al., 2009) and inserted by
phiC31 transgenesis into a second chromosome site at 51C (Bloo-
mington stock 24482).
4.2. Antibodies
Antibodies for western blot analysis: mouse anti-Bru (1:8000);
rat anti-BSF (1:1000); rat anti-Cup (1:2000); rabbit anti-Growl
(1:2000); rabbit anti-Hrp48 (1:10,000); rabbit anti-La (1:1000);
chicken anti-NS1 (1:1000); rabbit anti-Tral (1:10,000); mouse
anti-α-Tubulin (Sigma)(1:1000); alkaline phosphatase-conjugated
goat anti-rat IgG (Sigma)(1:5,000); alkaline phosphatase-con-
jugated goat anti-mouse IgG (Applied Biosystem)(1:5000). Anti-
bodies for imaging: mouse anti-HA (Covance)(1:1000); rabbit anti-
Osk (1:2000); mouse anti-Orb (4H8)(1:1); rabbit anti-BSF
(1:1000); Alexa Fluor 488 goat anti-mouse IgG (Invitrogen)
(1:800); Alexa Fluor 488 goat anti-rabbit IgG (Invitrogen)(1:800).4.3. oskC::S1 aptamer fusion RNAs for afﬁnity puriﬁcation
A plasmid with the S1 aptamer and a T7 promoter (from Craig
Smibert) was modiﬁed by addition of the ﬁnal 150 bp of the osk 3′
UTR (wt or mutant; ampliﬁed by PCR). Plasmids were linearized
with EcoRl (NEB), puriﬁed by phenol extraction and ethanol pre-
cipitation, and used as templates for transcription reactions. Fu-
sion RNA transcripts were synthesized and puriﬁed with the
MEGAscript T7 Kit according to the manufacturers instructions
(Ambion).
4.4. Preparation of ovary extract
Ovaries from young females (w1118) fed on yeast for 3–4 days
were dissected in 1 PBS on ice, washed once with ice cold
COEB100 (50 mM HEPES, pH 7.4, 10 mM MgCl2, 100 mM NaCl, 0.1%
Triton X-100, 10% Glycerol, 0.1 mM DTT, Complete, Mini, EDTA-free
protease inhibitor cocktail tablet (Roche)) and frozen at 80 °C.
Ovaries were thawed (all subsequent steps on ice or at 4 °C) and
homogenized with a plastic pestle in a 1.5 ml microfuge tube fol-
lowed by adding 10 ml of COEB100 per pair of ovaries. The lysate
was cleared by centrifugation at 12,000 rpm for 25 min and the
supernatent saved. Protein concentration in the extract was de-
termined by Bradford (Bio-rad) method, and the extract diluted to
1 mg/ml with COEB100. After centrifugation at 12,000 rpm for
25 min, extract was pre-incubated with 5 mg of soluble avidin
(Sigma) per 1 mg of protein for 15 min.
4.5. RNA afﬁnity puriﬁcation
Streptavidin agarose beads (Sigma) were equilibrated by
washing several times with OEB100 (50 mM HEPES, pH 7.4, 10 mM
MgCl2, 100 mM NaCl, 0.1% Triton X-100, 10% Glycerol, 0.1 mM DTT).
RNA for puriﬁcation (40 mg) was incubated with 35 ml of beads in
100 ml ice-cold OEB100 supplemented with 40 units/ml RNasin
(Promega) for 1 h at 4 °C with gentle rotation. The beads were
spun down, the supernatant removed, and 1 mg of pre-cleared
ovary extract (1 ml) added followed by incubation for 2 h at 4 °C
with rotation. After incubation, the beads were spun down, saving
both pellet and supernatant (S) fractions. The pellet fraction was
washed several times with ice-cold OEB100, and boiled in 35 ml of
6 protein sample buffer for 10 min to elute bound proteins (P). S
and P fractions were separated by SDS-PAGE and analyzed by
coomassie staining and western blot.
4.6. Whole-mount ovary staining
Sample preparation and antibody staining were performed as
described (Kim-Ha et al., 1995; Reveal et al., 2010). TO-PRO-3 Io-
dide (Invitrogen)(1:1000) was used to stain nuclei. Microscopy of
all samples made use of a Leica TCS-SP laser scanning confocal
microscope. For assignment of ﬂuorescence signal intensity into
classes (Figs. 2 and 4), all samples from a comparison group were
ﬁxed, stained and imaged in parallel, with gain and laser settings
such that the signal from wild type samples was not saturated. All
samples with intense posterior signal were placed in the “Strong”
category. Samples in which the signal was detectable but clearly
much weaker than normal were placed in the “Weak” category. If
no posterior signal was detectable, the samples were placed in the
“None” category.
4.7. In situ hybridization
In situ hybridization in ovary whole mount preparation was
performed as described (Jambor et al., 2014). Fluorescent RNA
probes were synthesized with DIG RNA labeling mix (Roche).
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Cuticle preparations (Wieschaus and Nüsslein-Volhard, 1986)
were mounted in Hoyer's Mounting Medium and viewed with a
Nikon Eclipse E600 microscope.
4.9. RNA–protein double staining in embryos
RNA–protein double staining was modiﬁed from (Lécuyer et al.,
2008). Brieﬂy, early-stage embryos were dechorionated with
bleach and ﬁxed with paraformaldehyde/heptane mix for 20 min.
The embryos were post-ﬁxed two times, and then incubated with
RNA probe overnight. After washing steps, the embryos were in-
cubated with the mouse anti-GFP (Santa Cruz) diluted at 1:200 for
2 h, followed by incubation with Alexa Fluor 488 goat anti-mouse
(Invitrogen) diluted at 1:800 for 1 h. After washing the embryos
were incubated with 1/50 diluted Cy5 tyramide (PerkinElmer) for
30 min and mounted on slides with Vectashield Mounting Med-
ium (Vector Labs), and imaged with Leica TCS-SP laser scanning
confocal microscope. Assignment of ﬂuorescence signal intensity
was the same as for ovary staining.
4.10. RNA preparation and qPCR analysis
Ovaries from young females fed on yeast for 3–4 days were
dissected into ice-cold PBS and late-stage egg chambers isolated.
Approximately 100 early-stage embryos were collected from fe-
males in the process of oviposition and dechorionated. Total RNAs
were isolated using Tri Reagent-LS (Molecular Research Center)
according to the manufacturer's protocol. RNA samples were
treated with DNase l (Qiagen) and puriﬁed with RNeasy MiniElute
Cleanup Kit (Qiagen). 1 mg of RNAs were used to synthesize cDNA
using iScript cDNA synthesis kit (Bio-rad) according to the man-
ufacturer's protocol. qPCR was carried out on a ViiATM 7 Real-Time
PCR system (Applied Biosystem) using iTaqTM Universal SYBR
s
Green Supermix (Bio-rad). Primers: α-tubulin, 5′-atgcgcgaag-
tagtctccatc-3′ and 5′-aggtgtcgtgacccacact-3′; mGFP6, 5′-tttcactg-
gagttgtcccaa-3′ and 5′-ggccatggaacaggtagttt-3′ (set1) and 5′-ag-
gacgacgggaactacaag-3′ and 5′-taagctcgatcctgttgacg-3′ (set 2).
4.11. RNA circularization and RT-PCR
RNAs were prepared as for qPCR. Gene speciﬁc oligo/RNase H
treatment was performed to remove mRNA 5′ caps. 2 mg RNA and
2.5 mg oligo 1 (5′-ggaattcacttgtgactgcg-3′) were mixed in 20 ml of
10 mM Tris–HCl, 50 mM NaCl, 1 mM EDTA (pH 8.0), incubated for
10 min at 70 °C and gradually cooled to 25 °C. The samples were
incubated for 1 h at 37 °C with 2.5 U of RNase H (NEB) and 20 U of
RNase Inhibitor, Human Placenta (HPRI, NEB) in 50 ml of RNase H
buffer (NEB). Decapped RNAs were puriﬁed with RNeasy MiniElute
Cleanup Kit (Qiagen).
For circularization, decapped RNA (1.5 mg) was incubated with
10 U of T4 RNA ligase (NEB) and 20 U of HPRI in 200 ml T4 RNA
ligase buffer, 0.1 mM ATP, and 10% PEG8000 for over 16 h at 16 °C.
Circularized RNAs (cRNAs) were precipitated with isopropanol
after extraction with phenol/chloroform, the cRNA pellets were
washed with 70% ethanol, and dissolved 8 ml nuclease free-dH2O.
cDNA was synthesized with the GeneAmp RNA PCR Kit (Applied
Biosystems), using 3 ml of cRNA and oligo 2 (5′-ggccatggaa-
caggtagttt-3′). PCR with oligo 2 and oligo 3 (5′-tctggatccttctggcg-
taatttacag-3′) was performed using Plantium PCR SuperMix (In-
vitrogen). PCR products were puriﬁed using ExoSAP-IP (Affyme-
trix) for direct sequencing and for cloning into pCRll-TOPO vector
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